ETF profile for State Street SPDR S&P Biotech ETF (XBI) from the issuer: top holdings, net assets, expense ratio and shares outstanding.

XBI ETF Profile

Name: XBI ETF Profile
Creator: Market Chameleon

Family:	State Street (SPDR)
Name:	State Street SPDR S&P Biotech ETF

Inception Date:	31-Jan-2006
Termination Date:
Investment Objective:	State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. The Index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The S&P TMI is designed to track the broad U.S. equity market. The biotechnology segment of the S&P TMI comprises the Biotechnology sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the "Select Industry Indices"), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ("GICS"). Membership in the Select Industry Indices is based on the GICS classification, as well as liquidity and market cap requirements.

Prospectus